CLINICAL_TRIALS
trial_result
· 2012-03-13
Clinical Trial Update: Prevention of Restenosis Following Revascularization [Phase 2]
Summary
Phase 2 clinical trial update for prevention of restenosis after revascularization; the trial was terminated but results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Celgene Corporation | Conditions: Vascular Disease, Peripheral | Phase 2 | Status: TERMINATED | Results posted: 2012-03-13